Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments. Genetic testing is a laboratory method ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

Supported by the stars of Full House, the campaign promoting Cologuard targets newly eligible 45+ adults with sitcom-style storytelling designed to reduce stigma and boost at-home screening uptake.

Atlantic Gastroenterology in Greenville, N.C., has opened a new genetic colon testing clinic, according a Daily Reflector report. Patients who come to the new clinic will receive a colorectal cancer ...

March marks Colorectal Cancer Awareness Month, bringing attention to one of the most common cancers in the United States.

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based ...

SALT LAKE CITY, Utah (Good Things Utah) – Colorectal cancer is the second most common cancer and the third leading cause of cancer related deaths in men and women under age 50. According to the ...

Colorectal cancer is increasing in young adults. Risk factors include age, metabolic syndrome, lifestyle choices, family ...

Dr. Rhee, who graduated from medical school in 2007 and has been at Maimonides for 13 years, told Brooklyn Paper that while ...